Global Expansion, Strategic Collaboration, Technologically Advanced Solutions, and First-of-a-Kind Project - Analyst Notes on Tableau, ServiceNow, Cavium, Infosys and IAC

Editor Note: For more information about this release, please scroll to bottom.

09 Jun, 2014, 05:20 ET from Analysts Review

NEW YORK, June 9, 2014 /PRNewswire/ --

Today, Analysts Review released its analysts' notes regarding Tableau Software Inc (NYSE: DATA), ServiceNow Inc. (NYSE: NOW), Cavium Inc. (NASDAQ: CAVM), Infosys Ltd ADR (NYSE: INFY) and IAC/InterActiveCorp (NASDAQ: IACI). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: -- Tableau Software Inc Analyst Notes On June 3, 2014, Tableau Software Inc (Tableau) announced its launch in India, driven by the sizeable domestic opportunity in the country. The Company has appointed Deepak Ghodke as head of its Indian operations, and his responsibilities include driving the sales growth and ensuring success of customers within the region. Ghodke has been assosciated with the company for six years. "Asia Pacific has been a fast-growing market for us. We are excited to launch in India and see tremendous promise in developing the market, as well as partnering with organizations to meet their data and business intelligence needs," said JY Pook, Vice President of Asia Pacific for Tableau. "The initial response we have received so far has been very encouraging and with Deepak's experience and expertise, we're looking forward to reaching a wider audience and further strengthening our presence in the region." The full analyst notes on Tableau are available to download free of charge at: -- ServiceNow Inc. Analyst Notes On June 4, 2014, ServiceNow Inc. (ServiceNow) announced that Envision Healthcare - a leading provider of physician-led, outsourced medical services, has implemented ServiceNow software-as-a-service for its Human Resources (HR) organization. The software was deployed with the help of the ServiceNow Professional Services organization and utilized Master Solutions Partner, Cloud Sherpas, to design new self-service portal. The Company informed that Envision Healthcare has automated its HR services, delivering standardized and consistent support for its employees, resulting in improvements in employee satisfaction and operational efficiencies. The full analyst notes on ServiceNow are available to download free of charge at: -- Cavium Inc. Analyst Notes On June 3, 2014, Cavium Inc. (Cavium) announced a collaboration with Oracle in support of Cavium's ThunderX processor family through which, Oracle plans to certify and optimize the upcoming port of Java Platform, Standard Edition 8 (Java SE 8) for the ARMv8 architecture for Cavium's ThunderX processors. "Our collaboration with Oracle is a strong message to the ThunderX software community that Cavium's support for the Java development community is a strategic priority," said Larry Wikelius, Director Thunder Ecosystems and Partner Enablement. "The multi-core scalability performance improvements recently demonstrated in Java 8 SE are particularly compelling for ThunderX. The combination of Oracle's technical leadership in Java with Cavium's leadership in multi-core silicon architecture and design is a big win for the server industry." The full analyst notes on Cavium are available to download free of charge at: -- Infosys Ltd ADR Analyst Notes On June 4, 2014, Infosys Ltd ADR (Infosys) announced that it has launched a cloud-based version of its Clinical Trial Supply Management (CTSM) solution that help life sciences companies enhance efficiency of clinical trial processes by driving greater collaboration between pharmaceutical companies and contract research organizations (CROs). Infosys claims that this solution will help improve the productivity of the overall drug development process, and help ensure timely and accurate supply of drugs to patients at reduced costs. Consequently, enterprises can price products competitively while still adhering to the strict standards in bringing products safely to consumers. "It is a solution that benefits from our experience in the sector, leveraging the power of SAP technology, and delivered through a cloud-based service," said Manish Tandon, Senior Vice President and Head of the Life Sciences, Infosys. The full analyst notes on Infosys are available to download free of charge at: -- IAC/InterActiveCorp Analyst Notes On May 29, 2014, Vimeo, LLC, an operating business of IAC/InterActiveCorp (IAC), announced its first original programming project with the signing of the critically-acclaimed web series from the husband-and-wife team, Katja Blichfeld and Ben Sinclair, "High Maintenance." According to the Company, as part of the deal, Vimeo will finance six new episodes to launch exclusively on Vimeo On Demand. IAC stated that director Blichfeld, actor Sinclair, and manager Russell Gregory at Regarding Entertainment first released High Maintenance on Vimeo in 2013. The 13-episode series earned regards as a "must-watch" original web series from critics for its well-crafted storylines and rotating cast that has included Downtown Abbey's Dan Stevens and comedian, Hannial Buress. The Company added that the new episodes are projected to launch later this year. Release schedule and pricing are yet to be determined. The full analyst notes on IAC are available to download free of charge at: -- About Analysts Review We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership. =============== EDITOR'S NOTES: =============== 1. This is not company news. We are an independent source and our views do not reflect the companies mentioned. 2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below. 3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public. 4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] 5. For any urgent concerns or inquiries, please contact us at compliance [at] 6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] for consideration. COMPLIANCE PROCEDURE Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be. NOT FINANCIAL ADVICE Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein. NO WARRANTY OR LIABILITY ASSUMED Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Analysts Review